Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-287265
Filing Date
2019-11-07
Accepted
2019-11-07 16:04:19
Documents
105
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d794789d10q.htm   iXBRL 10-Q 6323179
2 EX-31.1 d794789dex311.htm EX-31.1 10892
3 EX-31.2 d794789dex312.htm EX-31.2 10901
4 EX-32 d794789dex32.htm EX-32 4337
  Complete submission text file 0001193125-19-287265.txt   20971567

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA teva-20190930.xsd EX-101.SCH 89339
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20190930_cal.xml EX-101.CAL 61795
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20190930_def.xml EX-101.DEF 597741
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20190930_lab.xml EX-101.LAB 605623
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20190930_pre.xml EX-101.PRE 641108
106 EXTRACTED XBRL INSTANCE DOCUMENT d794789d10q_htm.xml XML 5235014
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 191200229
SIC: 2834 Pharmaceutical Preparations